PTPRZ1 and pancreatic neoplasm: The PPARα agonist clofibrate downregulates the expression of PTPRZ1 in pancreatic cancer cells, by abrogating the binding of nuclear factor-κB (NFκΒ) to the Ptprz1 promoter [20].